Colorectal carcinoma: from tumorigenesis to treatment

Cellular and Molecular Life Sciences : CMLS
Wei-Shu WangYeu Su

Abstract

Colorectal carcinoma (CRC) is a complicated and often fatal genetic disease. Fortunately, owing to rapid expansion of knowledge and technology development in oncology, much progress has been made regarding the diagnosis, understanding of the molecular genetics and malignant progression, as well as the novel regimens of CRC. In this review, we summarize the staging system, the most critical genetic and epigenetic alterations, the pleiotropic effects of MMP-7, the controversial roles of Hedgehog signaling, the intriguing involvement of thymosin beta-4, and the possible contribution of the putative colon (cancer) stem cells in CRC tumorigenesis. Current treatments as well as several potentially applicable therapeutic strategies for CRC are also discussed.

Citations

Oct 17, 2007·Journal of Cancer Research and Clinical Oncology·Guenter HofmannPeter Krippl
Mar 22, 2007·Journal of the National Cancer Institute·Stavroula RaptisBharati Bapat
Jan 26, 2011·European Journal of Histochemistry : EJH·S NemolatoG Faa
Jun 5, 2012·Experimental Cell Research·Swayamsiddha KarSamir Kumar Patra
Aug 11, 2010·Trends in Molecular Medicine·Monique T BarakatMatthew P Scott
Oct 2, 2007·Current Problems in Cancer·Russell P Kruzelock, William Short
Oct 10, 2007·Protein Expression and Purification·Xiankui LiShuhua Wu
Apr 25, 2007·Orvosi hetilap·Krisztina HagymásiZsolt Tulassay
Apr 18, 2015·Diagnostic Pathology·Tamás MicsikIstván Peták
Jun 15, 2010·The International Journal of Biochemistry & Cell Biology·Florian LangChristos Stournaras
Aug 9, 2007·International Journal of Cancer. Journal International Du Cancer·Guillaume ChatelRosita Winkler
Jan 15, 2013·International Journal of Colorectal Disease·Wei-Feng ChenLi-Qing Yao
Feb 2, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Chelsea S BahneyBrian Johnstone
Aug 24, 2013·Oncology Reports·Xin ZhengQingguang Liu
Jun 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wei-Shu WangYeu Su
Dec 6, 2020·Pathology, Research and Practice·Hanna HämetojaJaana Hagström

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.